AT306233B - Verfahren zur Herstellung neuer Cephalosporinderivate - Google Patents

Verfahren zur Herstellung neuer Cephalosporinderivate

Info

Publication number
AT306233B
AT306233B AT803370A AT803370A AT306233B AT 306233 B AT306233 B AT 306233B AT 803370 A AT803370 A AT 803370A AT 803370 A AT803370 A AT 803370A AT 306233 B AT306233 B AT 306233B
Authority
AT
Austria
Prior art keywords
preparation
cephalosporin derivatives
new cephalosporin
new
derivatives
Prior art date
Application number
AT803370A
Other languages
English (en)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Application granted granted Critical
Publication of AT306233B publication Critical patent/AT306233B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
AT803370A 1967-08-21 1968-08-20 Verfahren zur Herstellung neuer Cephalosporinderivate AT306233B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38494/67A GB1241657A (en) 1967-08-21 1967-08-21 Improvements in or relating to cephalosporin compounds

Publications (1)

Publication Number Publication Date
AT306233B true AT306233B (de) 1973-03-26

Family

ID=10403834

Family Applications (2)

Application Number Title Priority Date Filing Date
AT811468A AT303955B (de) 1967-08-21 1968-08-20 Verfahren zur Herstellung von Cephalosporinderivaten
AT803370A AT306233B (de) 1967-08-21 1968-08-20 Verfahren zur Herstellung neuer Cephalosporinderivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT811468A AT303955B (de) 1967-08-21 1968-08-20 Verfahren zur Herstellung von Cephalosporinderivaten

Country Status (10)

Country Link
US (1) US3658799A (de)
JP (2) JPS5010872B1 (de)
AT (2) AT303955B (de)
BE (1) BE719711A (de)
CA (1) CA927381A (de)
CH (2) CH561726A5 (de)
DE (2) DE1795184A1 (de)
FR (1) FR1589109A (de)
GB (1) GB1241657A (de)
NL (1) NL6811829A (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755256A (de) * 1969-08-26 1971-02-25 Glaxo Lab Ltd
US3922268A (en) * 1969-12-08 1975-11-25 Lilly Co Eli 3-Halomethyl-{66 {hu 3-Cephalosporin esters
DE2132883A1 (de) * 1970-07-08 1972-01-13 Ciba Geigy Ag Cephemverbindungen
IL38657A (en) * 1971-01-29 1979-01-31 Glaxo Lab Ltd Hydroxyimino-and -acyloxyimino-acylamido cephalosporins
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
GB1426072A (en) * 1973-01-18 1976-02-25 Beecham Group Ltd Cephalosporins
GB1459212A (en) * 1973-08-01 1976-12-22 Glaxo Lab Ltd N-deacylation of 7-acylamido-3-hydroxy-methyl cephalosporins
AR207327A1 (es) * 1974-02-06 1976-09-30 Lilly Co Eli Un procedimiento para preparar acidos 3-cefem 3-sulfonatos y sus esteres
US3890311A (en) * 1974-03-18 1975-06-17 American Home Prod 7-(2-(1-(phenylsulfonyl)-2-pyrrolidinylthio)acetamino)cephalosporanic acids
DK159154C (da) * 1975-02-24 1991-02-11 Takeda Chemical Industries Ltd Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf
US4048160A (en) * 1976-03-22 1977-09-13 Eli Lilly And Company Process for preparation of 7-alkoxy-3-bromomethylcephems
US4048163A (en) * 1976-03-22 1977-09-13 Eli Lilly And Company Process for preparation of 7-alkoxy-3-chloromethylcephems
US4042585A (en) * 1976-03-22 1977-08-16 Eli Lilly And Company Process for preparation of 3-halomethylcephems
US4144391A (en) * 1977-03-07 1979-03-13 Eli Lilly And Company Cephalosporin displacement reaction
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4266049A (en) * 1980-02-20 1981-05-05 Eli Lilly And Company Process for 3-iodomethyl cephalosporins
NL8005041A (nl) * 1980-09-05 1982-04-01 Gist Brocades Nv Werkwijze voor de bereiding van thioethers, alsmede gesilyleerde thiolen voor toepassing bij deze werkwijze.
DE3789412T2 (de) * 1986-10-02 1994-06-30 Asahi Chemical Ind Verfahren zur Herstellung von 3-Alkoxymethylcephalosporinen.
JP2612493B2 (ja) * 1988-05-24 1997-05-21 旭化成工業株式会社 3―置換メチル―3―セフェム―4―カルボン酸類の製造方法
US5302713A (en) * 1992-03-31 1994-04-12 Industrial Technology Research Institute Method for the preparation of Δ3 -7-substituted amino desacetoxy cephalosporanic acid
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
AT401177B (de) * 1993-10-22 1996-07-25 Biochemie Gmbh Verfahren zur herstellung von 7-amino-3-cephem-4-carbonsäure-derivaten
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
EP0814809B1 (de) * 1994-12-13 2003-08-13 Euroceltique S.A. Arylthioxanthine
DE69531555T2 (de) * 1994-12-13 2004-06-17 Euroceltique S.A. Dreifachsubstituierte thioxanthine
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US7423168B2 (en) * 2002-08-29 2008-09-09 Mitsubishi Chemical Corporation Method for producing allyl compound
WO2017153824A1 (en) 2016-03-07 2017-09-14 Dhanuka Laboratories Ltd. A process for alkylating the hydroxymethyl group at position -3 of cephalosporins

Also Published As

Publication number Publication date
AT303955B (de) 1972-12-27
JPS5010872B1 (de) 1975-04-24
CH561726A5 (de) 1975-05-15
NL6811829A (de) 1969-02-25
DE1795184A1 (de) 1972-03-16
FR1589109A (de) 1970-03-23
BE719711A (de) 1969-02-20
JPS5127679B1 (de) 1976-08-13
DE1795643A1 (de) 1972-11-09
CA927381A (en) 1973-05-29
US3658799A (en) 1972-04-25
CH561222A5 (de) 1975-04-30
GB1241657A (en) 1971-08-04

Similar Documents

Publication Publication Date Title
AT306233B (de) Verfahren zur Herstellung neuer Cephalosporinderivate
CH538494A (de) Verfahren zur Herstellung neuer Homopyrimidazol-Derivate
AT292193B (de) Verfahren zur Herstellung neuer 3,7-disubstituierter Cephalosporin-Derivate
CH542853A (de) Verfahren zur Herstellung neuer Isothiocyano-benzazol-Derivate
CH513111A (de) Verfahren zur Herstellung neuer Benz-epinderivate
CH497458A (de) Verfahren zur Herstellung neuer Phenothiazin-Derivate
AT294854B (de) Verfahren zur Herstellung neuer D-Glucofuranoside
CH498120A (de) Verfahren zur Herstellung neuer Indenopyridinderivate
AT278822B (de) Verfahren zur Herstellung neuer Pyrimidinderivate
CH513119A (de) Verfahren zur Herstellung neuer Halogencolchicinderivate
CH500972A (de) Verfahren zur Herstellung neuer Spiro-azatetramethylen-Derivate
CH542229A (de) Verfahren zur Herstellung neuer Benzothiopyranopyridin-derivate
CH510660A (de) Verfahren zur Herstellung neuer Glucofuranoside
AT288607B (de) Verfahren zur Herstellung neuer Nebularin-Derivate
AT293614B (de) Verfahren zur Herstellung neuer Cephalosporinderivate
CH462834A (de) Verfahren zur Herstellung neuer 6-Hydrazino-pyridazin-Derivate
AT293635B (de) Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstanderivate
CH532562A (de) Verfahren zur Herstellung neuer 3-Oxo-A-nor-B-homo-pregnatriene
AT283611B (de) Verfahren zur Herstellung neuer 3-Oxogonatrienderivate
AT297222B (de) Verfahren zur Herstellung neuer Rifamycin-Derivate
AT300806B (de) Verfahren zur Herstellung neuer Piperodin-Derivate
CH507261A (de) Verfahren zur Herstellung neuer Piperazin-Derivate
CH485756A (de) Verfahren zur Herstellung neuer Naphthyridin-Derivate
AT280502B (de) Verfahren zur Herstellung neuer 3-Oxogonatriene
AT286511B (de) Verfahren zur Herstellung neuer 4-Imino-19-nor-A-homo-steroid-triene

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee